Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2193-1801
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy ; volume:4 ; number:1 ; day:5 ; month:3 ; year:2015 ; pages:1-9 ; date:12.2015
SpringerPlus ; 4, Heft 1 (5.3.2015), 1-9, 12.2015

Urheber
Omoto, Yoko
Takeshita, Takashi
Yamamoto, Yutaka
Yamamoto-Ibusuki, Mutsuko
Hayashi, Mitsuhiro
Sueta, Aiko
Fujiwara, Saori
Taguchi, Tetsuya
Iwase, Hirotaka
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40064-015-0851-8
URN
urn:nbn:de:101:1-2019102806341318522400
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:22 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Omoto, Yoko
  • Takeshita, Takashi
  • Yamamoto, Yutaka
  • Yamamoto-Ibusuki, Mutsuko
  • Hayashi, Mitsuhiro
  • Sueta, Aiko
  • Fujiwara, Saori
  • Taguchi, Tetsuya
  • Iwase, Hirotaka
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Hochschulschrift

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Verbundene Objekte